2017-03-15,Zogenix To Participate In The Oppenheimer 27th Annual Healthcare Conference
2017-03-13,August 18th Options Now Available For Zogenix (ZGNX)
2017-03-10,Biotech Premarket Movers: ChemoCentryx, Jazz, Ionis, Zogenix
2017-03-09,Zogenix Provides Corporate Update And Reports Fourth Quarter And Full-Year 2016 Financial Results
2017-03-02,Zogenix To Release Fourth Quarter And Full-Year 2016 Financial Results And Host Conference Call And Webcast On March 9
2017-03-01,Zogenix Receives Orphan Drug Designation In The European Union For ZX008 In Lennox Gastaut Syndrome
2017-02-17,Notable Friday Option Activity: ZGNX, EPM, STZ
2017-02-15,Zogenix To Participate In The 2017 RBC Capital Markets Healthcare Conference
2017-02-13,Zogenix Announces Initiation Of Clinical Efficacy Portion Of Study 1504 For ZX008 In Dravet Syndrome
2017-02-08,Zogenix To Participate In The Leerink Partners 6th Annual Global Healthcare Conference
2017-02-02,These 5 Stocks Under $10 Could Light Up Soon
2017-01-30,Zogenix Announces Issuance Of U.S. Patent For ZX008 In Dravet Syndrome
2017-01-05,Zogenix Announces CFO Transition
2017-01-03,17 Thoughts on Biotech Stocks to Kick Off 2017
2016-12-05,Zogenix Announces New Efficacy And Safety Data For ZX008 In Treatment Of Seizures In Lennox Gastaut Syndrome & Dravet Syndrome
2016-11-22,New Data On Zogenix's ZX008 For Lennox Gastaut Syndrome & Dravet Syndrome To Be Presented At 70th Annual American Epilepsy Society Meeting
2016-11-22,Zogenix To Participate In Oppenheimer Life Sciences Summit 2016
2016-11-08,Depomed Reports Dip in Earnings, Reduces Revenue Guidance
2016-11-08,Zogenix To Participate In Stifel 2016 Healthcare Conference
2016-11-07,Zogenix Provides Corporate Update And Reports Third Quarter 2016 Financial Results
2016-10-31,Zogenix To Release Third Quarter 2016 Financial Results And Host Conference Call And Webcast On November 7
2016-10-12,Humana, Pharma Stocks Sink as Healthcare is Worst Performing Sector Wednesday
2016-09-20,Zogenix To Participate In Two Upcoming Investor Conferences
2016-09-08,Zogenix To Have Significant Presence At 12th European Congress On Epileptology
2016-08-09,Zogenix Provides Corporate Update And Reports Second Quarter 2016 Financial Results
2016-08-02,Zogenix To Release Second Quarter 2016 Financial Results And Host Conference Call And Webcast On August 9
2016-07-13,Commit To Buy Zogenix At $5, Earn 9.6% Annualized Using Options
2016-06-27,Zogenix Becomes Oversold (ZGNX)
2016-06-21,Zogenix Announces Agreement To Refinance Debt, Further Increasing Company's Expected 2017 Cash Balance
2016-06-07,Zogenix Announces Initiation Of Multi-National Phase 3 Clinical Trial For ZX008 In Dravet Syndrome
2016-05-31,Zogenix To Participate In Jefferies 2016 Healthcare Conference
2016-05-10,Zogenix Provides Corporate Update And Reports First Quarter 2016 Financial Results
2016-05-05,Zogenix Announces New Efficacy And Safety Data On ZX008 For Treatment Of Seizures In Dravet Syndrome
2016-05-03,Zogenix To Release First Quarter 2016 Financial Results And Host Conference Call And Webcast On May 10
2016-04-21,New Data On Zogenix's ZX008 For Dravet Syndrome To Be Presented At 14thÂ International Child Neurology Congress
2016-03-17,ZGNX: Insiders vs. Shorts
2016-03-17,Zogenix (ZGNX): Today's Weak On High Volume Stock
2016-03-10,Zogenix Provides Corporate Update And Reports Fourth Quarter And Full-Year 2015 Financial Results
2016-03-04,Zogenix To Release Fourth Quarter And Full-Year 2015 Financial Results And Host Conference Call And Webcast On March 10
2016-02-03,Zogenix To Participate In LEERINK Partners 5th Annual Global Healthcare Conference
2016-01-19,Zogenix Receives Fast Track Designation From FDA For Development Of ZX008 In Dravet Syndrome
2016-01-11,Commit To Buy Zogenix At $8, Earn 23.1% Using Options
2016-01-11,Zogenix Announces Initiation Of Phase 3 Program For ZX008 In Dravet Syndrome
2015-12-17,Insider Trading Alert - SCVL, ZGNX And FRME Traded By Insiders
2015-12-14,Zogenix Announces FDA Acceptance Of Investigational New Drug Application For ZX008 Phase 3 Clinical Trial In Dravet Syndrome
2015-12-09,Insider Trading Alert - RNST, AMPH And ZGNX Traded By Insiders
2015-12-07,Zogenix Announces New Efficacy And Safety Data On ZX008 For Treatment Of Seizures In Dravet Syndrome
2015-11-25,New Data On Zogenix's ZX008 For Dravet Syndrome To Be Presented At 69th Annual American Epilepsy Society Meeting
2015-11-11,Zogenix To Participate In Stifel 2015 Healthcare Conference
2015-11-09,Zogenix Provides Corporate Update And Reports Third Quarter 2015 Financial Results
2015-11-02,Zogenix To Release Third Quarter 2015 Financial Results And Host Conference Call & Webcast On November 9
2015-10-19,Zogenix Provides Regulatory Update For ZX008
2015-10-09,A Small Pharma Stock With Big Potential
2015-10-09,5 Stocks Ready for Breakouts
2015-09-30,Zogenix Reports Positive Top-Line Results From Relday(TM) Phase 1b Multi-Dose Clinical Trial
2015-09-23,Zogenix To Participate In The Leerink Partners 4th Annual Rare Disease Roundtable
2015-09-17,Fed's Non-Move Causes Whipsaw Action
2015-09-03,Zogenix To Participate In The Wells Fargo 2015 Healthcare Conference
2015-08-11,Ratings Changes Today
2015-08-10,Zogenix Provides Corporate Update And Reports Second Quarter 2015 Financial Results
2015-08-05,Zogenix Announces Closing Of Public Offering Of Common Stock, Including Full Exercise Of Underwriters' Option To Purchase Additional Shares
2015-08-03,Zogenix To Release Second Quarter 2015 Financial Results And Host Conference Call & Webcast On August 10
2015-07-30,Pre-Market Activity Shows Heavy Volume And Movement For Zogenix (ZGNX)
2015-07-30,Zogenix Prices Public Offering Of Common Stock
2015-07-28,Zogenix Announces Proposed Public Offering Of 3,800,000 Shares Of Common Stock
2015-07-16,Zogenix (ZGNX) Flagged As Strong On High Volume
2015-07-07,Zogenix To Host Key Opinion Leader Meeting Tuesday, July 14, In New York City
2015-07-06,Zogenix Expands Senior Leadership Team To Further Drive Strategic Focus On CNS Disorders And Orphan Drug Development
2015-07-06,Zogenix To Participate In Cantor Fitzgerald Healthcare Conference
2015-07-02,Today's Weak On High Volume Stock: Zogenix (ZGNX)
2015-06-29,Ratings Changes Today
2015-06-26,5 Stocks Ready for Breakouts
2015-06-25,Zogenix (ZGNX) Flagged As Strong On High Volume
2015-06-18,Zogenix Announces Shareholders And Board Of Directors Approve Reverse Stock Split
2015-05-29,Strong On High Volume: Zogenix (ZGNX)
2015-05-27,Zogenix Announces New Efficacy Data From A Long-Term Study Of Low-Dose Fenfluramine For Treatment Of Dravet Syndrome
2015-05-11,Zogenix Provides Corporate Update And Reports First Quarter 2015 Financial Results
2015-05-04,Zogenix To Release First Quarter 2015 Financial Results And Host Conference Call & Webcast On May 11
2015-04-27,Dr. Stephen Farr Appointed As CEO Of Zogenix To Lead New Strategic Focus And Advance Late-Stage CNS Product Pipeline
2015-04-24,Zogenix Closes Sale Of Zohydro(R) ER Business To Pernix
2015-04-02,Interesting ZGNX Put And Call Options For January 2017
2015-03-26,Zogenix Announces First Patient Dosed In Relday Multi-Dose Clinical Study
2015-03-21,Betting the Underdog Can Be Profitable
2015-03-12,How to Trade the Market's Most-Active Stocks
2015-03-11,Stocks Struggle to Recover but Fed Rate Hike Worries Persist
2015-03-11,Stocks Trying -- and Failing -- to Recover From Tuesday's Brutal Selloff
2015-03-11,Stocks Mixed as Crude Supplies Climb More Than Forecast
2015-03-11,Zogenix (ZGNX) Stock Declines Today Following Sale of Zohydro
2015-03-11,Zogenix (ZGNX) Highlighted As Weak On High Volume
2015-03-11,Stock Futures Prepare to Bounce Back After Tuesday's Selloff
2015-03-10,Zogenix Announces Agreement Of Sale Of Zohydro(R) ER Business To Pernix For $100 Million At Closing Plus Potential Milestones Of $283.5 Million
2015-03-10,Zogenix Reports Fourth Quarter And Full Year 2014 Financial Results
2015-03-02,Zogenix Announces Conference Call And Webcast To Present Fourth Quarter And Full Year 2014 Financial Results
2015-02-10,Zogenix Appoints Industry Veteran Renee Tannenbaum To Its Board Of Directors
2015-02-06,Zogenix an Odd Winner at the Ballot Box
2015-02-05,Zogenix To Participate In Leerink Global Healthcare Conference
2015-02-02,Zogenix (ZGNX) Stock Rises Today on Zohydro FDA Approval
2015-01-30,Zogenix Receives FDA Approval Of New Formulation Of Zohydro(R) ER
2015-01-12,Zogenix Provides Business Update
2014-12-30,Zogenix (ZGNX) Stock Gets a Boost Today From This Coverage Initiation
2014-12-03,Zogenix To Participate In Oppenheimer 25th Annual Healthcare Conference
2014-12-01,Results Of Long-Term, Open-Label Study Published In The Journal Of Pain Research Demonstrate The Safety, Tolerability And Effectiveness Of Zohydro(R) ER
2014-11-14,Shotgun Investing in Biotech
2014-11-12,Zogenix To Participate In Stifel 2014 Healthcare Conference
2014-11-06,Zogenix Reports Third Quarter 2014 Financial Results
2014-10-31,Zogenix And Purdue Pharma Exchange Waivers Of Regulatory Exclusivity For Extended-Release Hydrocodone Products
2014-10-30,Zogenix Announces Conference Call And Webcast To Present Third Quarter 2014 Financial Results
2014-10-27,Zogenix Acquires U.K.-Based Brabant Pharma
2014-10-03,5 Breakout Stocks Under $10 Set to Soar
2014-10-01,Zogenix Submits Modified Formulation Of Zohydro(R) ER With Potential Abuse Deterrent Properties For FDA Review
2014-09-18,New Data Shows Zohydro(R) ER Reduced Pain And Improved Function In People With Chronic Pain
2014-09-04,Education, Patient-Focused Approach To Treating Chronic Pain Are Keys To Preventing Opioid Abuse, Say Experts, Patients
2014-09-02,Zogenix To Participate In Morgan Stanley Global Healthcare Conference 2014
2014-09-02,Zohydro(R) ER Demonstrates Sustained 12-Hour Pain Relief
2014-08-19,First Week of April 2015 Options Trading For Zogenix (ZGNX)
2014-08-12,Zogenix Stock Sees Short Interest Move 13% Higher
2014-08-05,Zogenix Reports Second Quarter 2014 Financial Results
2014-08-01,Zogenix Announces Departure Of Chief Commercial Officer, Scott Shively
2014-07-22,Zogenix Announces Conference Call And Webcast To Present Second Quarter 2014 Financial Results
2014-07-17,Zogenix Announces Appointment Of David Brushwood, J.D., R.Ph., To External Safe Use Board
2014-07-14,Zogenix Announces New Patent Valid Through 2032 For DosePro(R) Needle-Free Delivery System
2014-07-09,Zogenix Reports Positive Development On U.S. District Court Ruling
2014-07-08,Why Zogeniz (ZGNX) Stock Is Tumbling Today
2014-07-02,Zogenix Provides Update On Development Of Abuse Deterrent Formulations Of Zohydro(R) ER
2014-06-16,Zogenix To Present At Two Upcoming Conferences
2014-06-02,Zogenix Reports Granting Of Inducement Awards
2014-06-02,Zogenix Officers To Report Withholding Of Shares
2014-05-30,Zogenix To Present At Jefferies 2014 Global Healthcare Conference
2014-05-19,Zogenix Closes Sale Of SUMAVEL(R) DosePro(R) Migraine Therapy To Endo International
2014-05-08,Zogenix Reports First Quarter 2014 Financial Results
2014-05-02,Zogenix Reports Granting Of Inducement Awards
2014-04-30,Zogenix Announces Conference Call And Webcast To Present First Quarter 2014 Financial Results
2014-04-24,Zogenix Announces Sale Of SUMAVEL(R) DosePro(R) Migraine Therapy To Endo International
2014-04-23,First Week of ZGNX June 21st Options Trading
2014-04-17,Biotech Stock Mailbag: NeoStem, Gilead and the Importance of Big-Cap Biotech Earnings
2014-04-16,Why Zogenix (ZGNX) Stock is Up Today
2014-04-11,Let's Get The Facts Straight About Zohydro&#8482; ER--and The Important Patient Need It Fills
2014-04-08,Zogenix Update On Legal Action
2014-04-07,Zogenix Takes Legal Action In Federal Court To Block Massachusetts Improper Ban On Zohydro&#8482; ER
2014-04-04,FDA, HHS Reaffirm Support For Chronic Pain Patients Amid Zohydro ER Debate
2014-04-02,Zogenix Statement: Let's Get The Facts Straight About Zohydro ER
2014-04-02,Zogenix Reports Granting Of Inducement Awards
2014-03-27,Zogenix Statement: Massachusetts Denies Patients A Legitimate Option For Severe Chronic Pain
2014-03-27,First Week Of May 17th Options Trading For Zogenix (ZGNX)
2014-03-26,Zogenix Appoints James Breitmeyer To Its Board Of Directors
2014-03-14,Why Zogenix (ZGNX) Is Down Today
2014-03-13,Why Zogenix (ZGNX) Is Down In After Market Close
2014-03-13,Why Zogenix (ZGNX) Is Up Today
2014-03-12,Why Zogenix (ZGNX) Is Down Big Today
2014-03-12,Perilous Reversal Stock: Zogenix (ZGNX)
2014-03-07,Trade-Ideas: Zogenix (ZGNX) Is Today's "Dead Cat Bounce" Stock
2014-03-07,Dr. Marsha Stanton Receives 2014 American Academy Of Pain Medicine Distinguished Service Award
2014-03-06,'Mad Money' Lightning Round: Steer Clear of Tesla
2014-03-05,Jim Cramer's 'Mad Money' Recap: Beware the Bears
2014-03-05,Zogenix Reports Fourth Quarter And Full Year 2013 Financial Results
2014-03-05,Zogenix Reports Granting Of Inducement Awards
2014-02-27,Zogenix Announces Conference Call And Webcast To Present Fourth Quarter And Full Year 2013 Financial Results
2014-02-26,First Week of ZGNX October 18th Options Trading
2014-02-13,Data From Zohydro(TM) ER (hydrocodone Bitartrate) Phase 3 Clinical Trial Published In Pain Medicine Demonstrates Its Benefit As A Therapeutic Option For The Management Of Pain Severe Enough To Require Daily, Around-the-Clock, Long-Term Opioid Treatment And For Which Alternative Treatment Options Are Inadequate
2014-02-12,Zogenix Establishes External Safe-Use Board
2014-02-11,Zogenix Provides Update On Zohydro(TM) ER (hydrocodone Bitartrate) Launch Readiness Plans
2014-02-06,5 Stocks Under $10 Set to Soar
2014-02-04,Zogenix To Present At Leerink Swann 2014 Global Healthcare Conference
2014-02-04,Zogenix Reports Granting Of Inducement Awards
2014-01-23,First Week Of ZGNX March 22nd Options Trading
2014-01-13,Zogenix Announces Preliminary Fourth Quarter 2013 Gross Product Sales
2014-01-09,Zogenix And Mallinckrodt Agree To End Co-Promotion For SUMAVEL(R) DosePro(R) Effective January 31, 2014
2014-01-07,Zogenix Reports Granting Of Inducement Awards
2013-12-26,Zogenix Stock Sees Short Interest Jump 12.5%
2013-12-20,Zogenix Reports Granting Of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
2013-12-17,Zogenix Appoints Chief Medical Officer And Expands Medical Leadership Team
2013-12-11,Zogenix Reports Granting Of Inducement Awards
2013-12-10,Zogenix Announces FDA Approval Of 4 Mg SUMAVEL(R) DosePro(R) (sumatriptan Injection) Needle-Free Delivery System
2013-12-04,Zogenix To Present At The Oppenheimer 24th Annual Healthcare Conference
2013-12-03,Zogenix And Battelle Expand DosePro Technology Business Agreement
2013-11-27,4 Stocks Under $10 Making Big Moves
2013-11-12,Zogenix Announces Closing Of Public Offering Of Common Stock, Including Full Exercise Of Over-Allotment Option By Underwriters
2013-11-05,Zogenix Prices Public Offering Of Common Stock
2013-11-04,Zogenix Announces Proposed Public Offering Of Common Stock
2013-11-04,Zogenix Reports Third Quarter 2013 Financial Results
